ARIAD Pharmaceuticals, Inc. (ARIA) today announced that Paris Panayiotopoulos, president and chief executive officer, will provide an overview of the Company’s business at two upcoming investor conferences:
- The Cowen and Company 36th Annual Health Care Conference being held in Boston on Wednesday, March 9, at 8:40 a.m. (ET)
- The Barclays Global Healthcare Conference being held in Miami on Thursday, March 17, at 8:00 a.m. (ET).
The ARIAD presentations will be webcast live and can be accessed by visiting the investor relations section of the Company’s website athttp://www.ariad.com/investor. Replays of these presentations will also be available and archived on the site for three weeks.
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. ARIAD is working on new medicines to advance the treatment of various forms of chronic and acute leukemia, lung cancer and other difficult-to-treat cancers. ARIAD utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines. For additional information, visithttp://www.ariad.com or follow ARIAD on Twitter (@ARIADPharm).
Maria Cantor, 617-621-2208
Liza Heapes, 617-621-2315